Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06121869 · ClinicalTrials.gov registry record · NA

Dileucine and Resistance Training Adaptations

A NA study of Hypertrophy and Strength Training Adaptations, sponsored by Lindenwood University.

Completed
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT06121869 is a NA study of Hypertrophy and Strength Training Adaptations that has completed, run by Lindenwood University. The registered enrollment target is 34 participants, above the 30-participant average among 4 other Hypertrophy trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06121869, a NA study of Hypertrophy and Strength Training Adaptations, has completed, sponsored by Lindenwood University.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

This study seeks to compare the observed changes in resistance training adaptations after supplementation of isomolar amounts of leucine or dileucine in healthy resistance-trained men. This will provide a better understanding of supplementation with leucine versus dileucine over a 10-week period in regards to increasing muscular performance.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Leucine
  • DIETARY_SUPPLEMENT Dileucine

Study Locations (1)

Missouri

  • Exercise and Performance Nutrition Laboratory - Saint Charles

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2021-05-07
Est. Completion 2023-06-29
Phase NA

Sponsor

Lindenwood University

29 total trials

What the Registry Record Tells You About NCT06121869

The ClinicalTrials.gov registry entry for NCT06121869 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 30-participant average among 4 other Hypertrophy trials with a reported enrollment target (13% higher). The listed sponsor is Lindenwood University, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertrophy appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT06121869 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT06121869 about?

NCT06121869 is a clinical study titled "Dileucine and Resistance Training Adaptations". This study seeks to compare the observed changes in resistance training adaptations after supplementation of isomolar amounts of leucine or dileucine in healthy resistance-trained men. This will provide a better understanding of supplementation with leucine versus dileucine over a 10-week period in ...

What is the current status of trial NCT06121869?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2021-05-07. Estimated completion is 2023-06-29.

What conditions does trial NCT06121869 study?

This clinical trial studies the following conditions: Hypertrophy, Strength Training Adaptations, Weight-Bearing Strengthening Program.

What interventions are being tested in trial NCT06121869?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Leucine (DIETARY_SUPPLEMENT), Dileucine (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06121869?

This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06121869 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertrophy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.